Delivery Order SPE2DB25D3504-SPE2DB25FVTFR

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 50 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,085.64, is a firm-fixed-price delivery order with an ultimate completion date of August 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as the primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lamotrigine ER 300 mg tablets, a medication used to treat conditions such as epilepsy and bipolar disorder. The contract has a ceiling value of $6,467.68 and is set to run until January 30, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Lamotrigine ER 200 mg tablets, a prescription medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 2, 2022, with a completion date of February 3, 2022. The ceiling value of the delivery order is $2,298.32. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through full and open...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lamotrigine ODT 50 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,125.81 and a period of performance through January 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,111.01 firm fixed-price delivery order is for the supply of 4,564,449,522 lamotrigine orally disintegrating tablets (100 mg, 30 count) with a completion date of May 1, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 25 mg tablets. The $1,990.68 firm fixed-price contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,843.10, is for the delivery of Lamotrigine ER 300 mg tablets to support military healthcare programs. The contract has an ultimate completion date of July 29, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,401.79, is for the delivery of Lamotrigine ODT 100 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing model. The contract has a period of performance through November 7, 2024 and was awarded on November 6, 2024. There was no set-aside designation for this...
This federal contract award, valued at $6,223.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LAMOTRIGINE ER 50 MG TABLET 30S, a generic prescription medication. The contract has an ultimate completion date of September 5, 2024 and is a firm fixed-price delivery order, with no set-aside requirements. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,150.57, is a delivery order for 4566307596 - LAMOTRIGINE ER 250 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVTFR
    Delivery Order

This federal contract award is for the delivery of lamotrigine extended-release 300 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 31, 2025 with a ceiling value of $1,722.27 and a completion date of February 3, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/2/25, 9:53 AM